Efficacy of Tranexamic Acid in Brain Tumor Resections

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Tranexamic Acid is effective or not in the reduction of intraoperative bleeding loss in brain tumors resections.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Colombian Foundation for Epilepsy and Neurological Disease
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Patients who agree to participate by giving informed consent

• Eligible previously untreated patients with resectable brain tumor.

Exclusion Criteria:

• Patients with previous thromboembolic events.

• Patients with coagulopathy or anticoagulation therapy. (Abnormal PT, PTT)

• Patients with impaired renal function (Creatinine >1.1mg/dl)

• Patients with known contraindications to fibrinolytic treatment.

• Patients receiving rejection therapy.

• Patients with abnormal liver function.

• Known allergies to Tranexamic Acid.